Table Info

Table 4.

Comparison of spirometric parameters in patients with BA in patients with normal body weight, overweight, and obesity (girls)

Parameters	Group 1 (normal body weight, N = 76)	Group 2 (overweight, N = 30)	Group 3 (obesity, N = 10)	KWT	P-value
Z FVC	1.05 [0.29; 1.91]	1.49 [0.86; 2.29]	1.58 [0.58; 1.91]	4.88	0.09
Z FEV₁	0.19 [–0.47; 0.70]	0.50 [–0.11; 1.13]	0.29 [–0.54; 0.87]	2.99	0.22
FEV₁/FVC (%)	81.53 [73.75; 86.35]	80.34 [74.83; 82.87]	77.63 [74.62; 78.95]	2.33	0.31
Z FEV₁/FVC	–1.28 [–2.14; –0.44]	–1.35 [–2.03; –0.93]	–1.63 [–2.00; –1.56]	1.98	0.37
MEF_25% (%)	67.07 [49.81; 88.00]	73.59 [47.89; 82.74]	51.59 [41.07; 71.96]	2.47	0.29
FEF_25–75% (%)	77.16 [56.97; 98.40]	79.33 [65.95; 88.60]	73.65 [52.56; 78.53]	1.47	0.48
DR (%)	0.76 [0.57; 0.93]	0.74 [0.59; 0.85]	0.74 [0.58; 0.87]	1.96	0.37

P < 0.05 represents a significant difference in results. KWT: Kruskall-Wallis test; N: number

Declarations

Author contributions

TIE: Conceptualization, Writing—original draft, Project administration. OVK: Methodoly. LAO: Investigastion. EVT: Data curation. RNK: Formal analysis, Validation. GSI: Supervision. VAB: Project administration. DYO: Writing—review & editing. All authors contributed to manuscript revision, read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study was conducted in accordance with the Helsinki Declaration (2013) and approved by the Ethics Committee of the Privolzhsky Research Medical University No. 13 dated October 10th, 2016.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

The datasets for this manuscript are not publicly available because: we are continuing the research, and the datasets will be available as we complete the description.

Funding

Not applicable.

Copyright

References

Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18:715–23. [DOI] [PubMed]

Marillier M, Bernard AC, Reimao G, Castelli G, Alqurashi H, O’Donnell DE, et al. Breathing at extremes: the restrictive consequences of super- and super-super obesity in men and women. Chest. 2020;158:1576–85. [DOI] [PubMed]

Jung Y, Jean T, Morphew T, Galant SP. Peripheral airway impairment and dysanapsis define risk of uncontrolled asthma in obese asthmatic children. J Allergy Clin Immunol Pract. 2022;10:759–67.E1. [DOI] [PubMed]

Arismendi E, Bantulà M, Perpiñá M, Picado C. Effects of obesity and asthma on lung function and airway dysanapsis in adults and children. J Clin Med. 2020;9:3762. [DOI] [PubMed] [PMC]

Forno E, Han YY, Mullen J, Celedón JC. Overweight, obesity, and lung function in children and adults—a meta-analysis. J Allergy Clin Immunol Pract. 2018;6:570–81.E10. [DOI] [PubMed] [PMC]

Forno E, Weiner DJ, Mullen J, Sawicki G, Kurland G, Han YY, et al. Obesity and airway dysanapsis in children with and without asthma. Am J Respir Crit Care Med. 2017;195:314–23. [DOI] [PubMed] [PMC]

Dumas O, Varraso R, Gillman MW, Field AE, Camargo CA Jr. Longitudinal study of maternal body mass index, gestational weight gain, and offspring asthma. Allergy. 2016;71:1295–304. [DOI] [PubMed] [PMC]

Ripoll JG, Guo W, Andersen KJ, Baker SE, Wiggins CC, Shepherd JRA, et al. Sex differences in paediatric airway anatomy. Exp Physiol. 2020;105:721–31. [DOI] [PubMed] [PMC]

Krol KA, Litonjua AA. Beyond obesity: the complex relationship between early growth trajectories and later lung function. J Allergy Clin Immunol. 2021;148:713–5. [DOI] [PubMed]

10.

Child growth standards [Internet]. Geneva: World Health Organization; c2023 [cited 2018 Apr 23]. Available from: https://www.who.int/tools/child-growth-standards

11.

Age-based pediatric growth reference charts [Internet]. Houston: Baylor College of Medicine; c2023 [cited 2018 Apr 23]. Available from: https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html

12.

Global Lung Function Initiative calculators for spirometry, TLCO and lung volume [Internet]. Credit to Global Lung Function Initiative; [cited 2018 Apr 23]. Available from: http://gli-calculator.ersnet.org/index.html

13.

Vilozni D, Lavie M, Sarouk I, Efrati O. Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation? Am J Respir Crit Care Med. 2012;186:82–7. [DOI] [PubMed]

14.

Juniper EF, Bousquet J, Abetz L, Bateman ED; GOAL Committee. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616–21. [DOI] [PubMed]

15.

Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200:e70–88. [DOI] [PubMed] [PMC]

16.

Khrisanapant W, Sengmeuang P, Kukongviriyapan U, Pasurivong O, Pakdeechotel P. Plasma leptin levels and a restrictive lung in obese Thai children and adolescents. Southeast Asian J Trop Med Public Health. 2015;46:116–24. [PubMed]

17.

Xu XW, Huang Y, Wang J, Zhang XL, Liang FM, Luo R. Effect of obesity on pulmonary function in asthmatic children of different age groups. Chin J Contemp Pediatr. 2017;19:519–23. Chinese. [PubMed] [PMC]

18.

Han YY, Forno E, Celedón JC. Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children. Am J Respir Crit Care Med. 2014;190:32–9. [DOI] [PubMed] [PMC]

19.

Huang F, Del-Río-Navarro BE, Torres-Alcántara S, Pérez-Ontiveros JA, Ruiz-Bedolla E, Saucedo-Ramírez OJ, et al. Adipokines, asymmetrical dimethylarginine, and pulmonary function in adolescents with asthma and obesity. J Asthma. 2017;54:153–61. [DOI] [PubMed]

20.

Khramova RN, Tush EV, Khramov AA, Ovsyannikov DY, Popov KS, Dolbin IV, et al. Relationship of nutritional status and spirometric parameters in children with bronchial asthma. Sovrem Tekhnologii Med. 2021;12:12–23. [DOI] [PubMed] [PMC]

21.

Bekkers MB, Wijga AH, Gehring U, Koppelman GH, de Jongste JC, Smit HA, et al. BMI, waist circumference at 8 and 12 years of age and FVC and FEV₁ at 12 years of age; the PIAMA birth cohort study. BMC Pulm Med. 2015;15:39. [DOI] [PubMed] [PMC]

22.

Köchli S, Endes K, Bartenstein T, Usemann J, Schmidt-Trucksäss A, Frey U, et al. Lung function, obesity and physical fitness in young children: the EXAMIN YOUTH study. Respir Med. 2019;159:105813. [DOI] [PubMed]

23.

Satapathy AK, Das RR, Mahapatro S, Panigrahi MK, Bandopadhaya D. Effect of body mass index (BMI) on pulmonary functions in children of 6–14 years of age: a cross-sectional study. J Family Med Prim Care. 2022;11:3156–60. [DOI] [PubMed] [PMC]

24.

Lang JE. Obesity and childhood asthma. Curr Opin Pulm Med. 2019;25:34–43. [DOI] [PubMed]

25.

Jones MH, Roncada C, Fernandes MTC, Heinzmann-Filho JP, Sarria Icaza EE, Mattiello R, et al. Asthma and obesity in children are independently associated with airway dysanapsis. Front Pediatr. 201718;5:270. [DOI] [PubMed] [PMC]

26.

Holmes MV, Pulit SL, Lindgren CM. Genetic and epigenetic studies of adiposity and cardiometabolic disease. Genome Med. 2017;9:82. [DOI] [PubMed] [PMC]

27.

Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29:1028–44. [DOI] [PubMed] [PMC]

28.

Imboden M, Wielscher M, Rezwan FI, Amaral AFS, Schaffner E, Jeong A, et al. Epigenome-wide association study of lung function level and its change. Eur Respir J. 2019;54:1900457. [DOI] [PubMed] [PMC]

29.

Reed ZE, Suderman MJ, Relton CL, Davis OSP, Hemani G. The association of DNA methylation with body mass index: distinguishing between predictors and biomarkers. Clin Epigenetics. 2020;12:50. [DOI] [PubMed] [PMC]